Program Book - Confex

ACR Poster Session A
340. Performance of the American College of Rheumatology/
European League Against Rheumatism (2011) Remission
Definition Versus Disease Activity Score, 28-Joint Disease
Activity Score and American College of Rheumatology
Criteria. Karla Chiapas-Gasca, Luis M. Amezcua-Guerra and
Angélica Vargas, Instituto Nacional de Cardiología Ignacio
Chávez, Mexico City, Mexico
341. What Is A Realistic Treatment Target in Rheumatoid
Arthritis: Remission or Minimal Disease Activity Yvonne
M.R. de Punder 1 , Jaap Fransen 1 , Wietske Kievit 1 , Pieternella
Houtman 2 , Henk Visser 3 , Mart A.F.J. van de Laar 4 and Piet
LC van Riel 1 , 1 Radboud University Nijmegen Medical Centre,
Nijmegen, Netherlands, 2 Medical Centre Leeuwarden,
Leeuwarden, Netherlands, 3 Alysis Care Group, Arnhem,
Netherlands, 4 Arthritis Centre Twente, Medisch Spectrum
Twente and University Twente, Enschede, Netherlands
342. Consensus Among Patients and Health Care Professionals
for Essential Domains to Assess Disease Flares in
Rheumatoid Arthritis: Results of Final OMERACT Delphi.
Susan J. Bartlett 1 , Thasia G. Woodworth 2 , Clifton O. Bingham
III 3 , Rieke Alten 4 , Christoph Pohl 5 , Ernest Choy 6 , Sarah
Hewlett 7 , Tessa Sanderson 7 , Annelies Boonen 8 , Vivian
Bykerk 9 , Amye L. Leong 10 , Vibeke Strand 11 , Daniel E. Furst 12 ,
Robin Christensen 13 and OMERACT Flare Working Group,
1
McGill University, Montreal, QC, 2 Leading Edge Clinical
Research, Stuart, FL, 3 Johns Hopkins University, Baltimore,
MD, 4 Rheumatology Schlossparkklinik, Berlin, Germany,
5
Schlosspark Klinik, Berlin, Germany, 6 Cardiff University,
Cardiff, ENGLAND, United Kingdom, 7 University of the West
of England, Bristol, United Kingdom, 8 University Hospital
Maastricht, Maastricht, Netherlands, 9 Brigham & Women’s
Hospital, Boston, MA, 10 Bone & Joint Decade, Santa Barbara,
CA, 11 Stanford University, Palo Alto, CA, 12 UCLA Medical
School, Los Angeles, CA, 13 Copenhagen, Denmark
343. Development and Validation of a New Disease Activity
Index As a Numerical Sum of 4 Variables, Including
Erythrocyte Sedimentation Rate and/or C-Reactive Protein,
to Assess Rheumatoid Arthritis. Isabel Castrejón 1 , Loreto
Carmona 2 , Ana M. Ortiz 3 , Miguel A. Belmonte Serrano 4 ,
Juan A. martínez-López 5 and Isidoro González-Alvaro 3 , 1 NYU
Hospital for Joint Diseases, New York, NY, 2 Universidad
Camilo José Cela, Villanueva de la Cañada, Spain, 3 Hospital
Universitario de La Princesa. IIS Princesa, Madrid, Spain,
4
Hospital General de Castellon, Castellon, Spain, 5 Fundación
Jimenez Díaz, Madrid, Spain
344. Investigation of the Relationship Between Patient-
Centered Factors and Baseline Disease Activity (DAS28) in
Rheumatoid Arthritis (RA). Rita Prajapati 1 , Darren Plant 2 ,
Deborah Maskell 2 , Ann W. Morgan 3 , Anthony G. Wilson 4 ,
John Isaacs 5 , Lis Cordingley 1 and Anne Barton 1 , 1 University of
Manchester, Manchester, United Kingdom, 2 The University
of Manchester, Manchester, United Kingdom, 3 NIHR-Leeds
Biomedical Research Unit and Leeds Institute of Molecular
Medicine, University of Leeds, Leeds, United Kingdom,
4
Sheffield Uni /Medical School, Sheffield, United Kingdom,
5
Newcastle University, Newcastle upon Tyne, United
Kingdom
345. To Screen Remission without Formal Joint Count: Analysis
of Routine Assessment of Patient Index Data 3 in Japanese
National Database. Naoto Yokogawa 1 , Kota Shimada 1 ,
Shoji Sugii 1 and Shigeto Tohma 2 , 1 Tokyo Metropolitan Tama
Medical Center, Tokyo, Japan, 2 Clinical Research Center for
Allergy and Rheumatology, Sagamihara National Hospital,
National Hospital Organization, Sagamihara, Japan
346. The Clinical Characteristics of Rheumatoid Arthritis
Patients in Clinical Remission: Many Faces of DAS-28
Remission. Kyeong Min Son 1 , Inje Kim 2 and Hyun Ah Kim 1 ,
1
Hallym university sacred heart hospital, Kyunggi, South
Korea, 2 Hallym University Kangdong Sacred Heart hospital,
Seoul, South Korea
347. Clinical Outcome in Early Undifferentiated Arthritis Is Best
Predicted by a Combination of Baseline Clinical Features
and Serum Biomarkers. Carol A. Hitchon 1 , Gilles Boire 2 ,
Michael Centola 3 , Andrew Lloyd 4 , Richard Kay 4 and Hani
S. El-Gabalawy 1 , 1 University of Manitoba, Winnipeg, MB,
2
CHUS - Sherbrooke University, Sherbrooke, QC, 3 Oklahoma
Medical Research Fdn, Oklahoma City, OK, 4 Astra-Zeneca,
Cheshire, United Kingdom
348. Early Increase In Serum-COMP Is Associated with Joint
Damage Progression Over the First Five Years In Patients
with Rheumatoid Arthritis. Maria LE Andersson 1 , Bjorn
Svensson 2 , Ingemar F. Petersson 3 , Ingiald Hafstrom 4 , Kristina
Albertsson 4 , Kristina Forslind 5 , Dick Heinegard 6 and Tore
Saxne 7 , 1 R&D centre, Spenshult Hospital for Rheumatic
Diseases, Oskarstrom, Sweden, Oskartrom, Sweden,
2
Paulinsvag 7D, Bastad, Sweden, 3 Lund University Hosp,
Lund, Sweden, 4 Karoliska Institute, Stockholm, Sweden,
5
Lund, Sweden, 6 University of Lund, Lund, Sweden, 7 Dept
of Clinical Sciences Lund, Section of Rheumatology, Lund,
Sweden
349. Is There An Association Between Uric Acid and
Inflammation in Patients with Rheumatoid Arthritis
Paola de Pablo 1 , Vasileios F. Panoulas 2 , Karen MJ Douglas 2 ,
Christopher D. Buckley 1 and George Kitas 2 , 1 University of
Birmingham, College of Medical & Dental Sciences, School
of Immunity & Infection, Rheumatology, Birmingham,
United Kingdom, 2 Dudley Group of Hospitals NHS Trust,
Russells Hall Hospital, Dudley, West Midlands, UK, Dudley,
United Kingdom
350. Baseline Serum Levels of CXCL13 Are Associated with
Ultrasonographic Synovitis and Predict Power Doppler
Persistency in Early Rheumatoid Arthritis. Antonio Manzo,
Serena Bugatti, Francesca Benaglio, Barbara Vitolo, Monica
Todoerti, Garifallia Sakellariou, Roberto Caporali and
Carlomaurizio Montecucco, Division of Rheumatology,
University of Pavia School of Medicine, IRCCS Policlinico San
Matteo Foundation, Pavia, Italy
2011 Program Book 159